➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Baxter
Merck
Harvard Business School
Boehringer Ingelheim
Mallinckrodt

Last Updated: June 16, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Alovudine


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Alovudine?

Alovudine is an investigational drug.

There have been 6 clinical trials for Alovudine. The most recent clinical trial was a Phase 2 trial, which was initiated on February 6th 2018.

The most common disease conditions in clinical trials are HIV Infections, Immunologic Deficiency Syndromes, and Acquired Immunodeficiency Syndrome. The leading clinical trial sponsors are Lederle Laboratories, National Cancer Institute (NCI), and ECOG-ACRIN Cancer Research Group.

Recent Clinical Trials for Alovudine
TitleSponsorPhase
Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node InvolvementNational Cancer Institute (NCI)Phase 2
Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node InvolvementECOG-ACRIN Cancer Research GroupPhase 2
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and ChemotherapyNational Cancer Institute (NCI)Phase 2

See all Alovudine clinical trials

Clinical Trial Summary for Alovudine

Top disease conditions for Alovudine
Top clinical trial sponsors for Alovudine

See all Alovudine clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Moodys
Medtronic
Dow
Boehringer Ingelheim
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.